Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Tendera

Showing results (71-80 of 131) with videos related to

Pageof 14
Sort By:
Plos One|July 23, 2014
Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patientsPaul R Kalra, Xavier García-Moll, José Zamorano, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 29, 2012
The new oral adenosine A1 receptor agonist capadenoson in male patients with stable anginaMichal Tendera, Ewa Gaszewska-Żurek, Zofia Parma, et al.
Archives of Cardiovascular Diseases|July 31, 2023
Association between coffee or tea consumption and cardiovascular outcomes in patients with stable coronary artery disease: Analysis from the CLARIFY registryJeremie Abtan, Gregory Ducrocq, Yedid Elbez, et al.
Open Heart|February 17, 2025
Hypertrophic cardiomyopathy and atrial fibrillation: the Cardiomyopathy/Myocarditis Registry of the EURObservational Research Programme of the European Society of CardiologyKatarzyna Mizia-Stec, Juan R Gimeno, Philippe Charron, et al.
European Heart Journal|March 18, 2006
The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heartJozef Bartunek, Stephanie Dimmeler, Helmut Drexler, et al.
Lancet (London, England)|August 31, 2018
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trialJ Michael Gaziano, Carlos Brotons, Rosa Coppolecchia, et al.
Revista Espanola De Cardiologia|March 31, 2007
[Trends and contexts in European cardiology practice for the next 15 years. The Madrid Declaration: a report from the European Conference on the Future of Cardiology, Madrid, 2-3 June 2006]Javier Escaned, Lars Rydén, José Luis Zamorano, et al.
JAMA Internal Medicine|August 12, 2014
Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY RegistryPhilippe Gabriel Steg, Nicola Greenlaw, Michal Tendera, et al.
European Journal of Preventive Cardiology|April 18, 2025
Smoking Trajectories and Residual Cardiovascular Risk in Patients with Stable Coronary Artery Disease: An international Cohort StudyJules Mesnier, Louis Giovachini, Grégory Ducrocq, et al.
European Journal of Preventive Cardiology|September 28, 2019
Relationship between physical activity and long-term outcomes in patients with stable coronary artery diseaseSimone Biscaglia, Gianluca Campo, Emmanuel Sorbets, et al.
Pageof 14

Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
Plos One|July 23, 2014
Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patientsPaul R Kalra, Xavier García-Moll, José Zamorano, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 29, 2012
The new oral adenosine A1 receptor agonist capadenoson in male patients with stable anginaMichal Tendera, Ewa Gaszewska-Żurek, Zofia Parma, et al.
Archives of Cardiovascular Diseases|July 31, 2023
Association between coffee or tea consumption and cardiovascular outcomes in patients with stable coronary artery disease: Analysis from the CLARIFY registryJeremie Abtan, Gregory Ducrocq, Yedid Elbez, et al.
Open Heart|February 17, 2025
Hypertrophic cardiomyopathy and atrial fibrillation: the Cardiomyopathy/Myocarditis Registry of the EURObservational Research Programme of the European Society of CardiologyKatarzyna Mizia-Stec, Juan R Gimeno, Philippe Charron, et al.
European Heart Journal|March 18, 2006
The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heartJozef Bartunek, Stephanie Dimmeler, Helmut Drexler, et al.
Lancet (London, England)|August 31, 2018
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trialJ Michael Gaziano, Carlos Brotons, Rosa Coppolecchia, et al.
Revista Espanola De Cardiologia|March 31, 2007
[Trends and contexts in European cardiology practice for the next 15 years. The Madrid Declaration: a report from the European Conference on the Future of Cardiology, Madrid, 2-3 June 2006]Javier Escaned, Lars Rydén, José Luis Zamorano, et al.
JAMA Internal Medicine|August 12, 2014
Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY RegistryPhilippe Gabriel Steg, Nicola Greenlaw, Michal Tendera, et al.
European Journal of Preventive Cardiology|April 18, 2025
Smoking Trajectories and Residual Cardiovascular Risk in Patients with Stable Coronary Artery Disease: An international Cohort StudyJules Mesnier, Louis Giovachini, Grégory Ducrocq, et al.
European Journal of Preventive Cardiology|September 28, 2019
Relationship between physical activity and long-term outcomes in patients with stable coronary artery diseaseSimone Biscaglia, Gianluca Campo, Emmanuel Sorbets, et al.
Pageof 14